 Thanks, Dr. Berg, for that introduction. Thank you for the Brain Foundation sponsors, donors, committee members, and staff for awarding this research gift. I'm extremely grateful. I also accept this award on behalf of my co-investigator, Professor Meng Loh, who couldn't be here today. I'm a neurologist with sub-specialty expertise in neuromuscular medicine, and I work at the Alfred Hospital. It's interesting to mention stories and stories of the Brain Foundation. My story in neurology sort of began in stroke in brain imaging in stroke, and it's sort of my formal training in neurology finished at the Mayo Clinic, actually working in neuromuscular diseases, and it's here where I developed a keen interest in deep phenotyping of nerve and muscle disorders. And phenotyping is essentially the story that nerves and muscles tell us. This research project draws on my previous prior experience in imaging of brain blood flow in stroke and to utilize similar techniques to study the blood flow in nerves and muscles and disease. Nerve and muscle disorders, enjoying somewhat of a renaissance recently. They've been an advent of new treatments for disorders that have up to recently been considered untreatable. However, there remains uncertainty as to who should receive this treatment when we should start this treatment, and more importantly, when we should stop treatment. It is our hope that by using neural imaging techniques to study the blood flow in proximal nerve segments, we'll be able to develop a biomarker that'll be aid in the phenotyping and storytelling of complex nerve and muscle disorders. This is relatively uncharted territory in the field of nerve and muscle disorders at least, but as potential significantly improved patient outcomes by early identification of nerve disorders and reduced morbidity by tailoring treatment strategies. I would like to once again thank the Brain Foundation for providing this opportunity and to share the story with the rest of Australia and the world. Thank you.